Actively Recruiting
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-02-04
160
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a purely retrospective and observational monocentric study
CONDITIONS
Official Title
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018.
- Age 63; 18 years at enrolment.
- Written informed consent (if applicable)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
Research Team
P
Pier Luigi Zinzani, MD
CONTACT
A
Alessandro Broccoli, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here